Archive for the 'Blog' Category

* The Diabetes Care Project Kicks-off Initiatives to Improve Health Outcomes for People with Diabetes *

Study Finds Medicare Beneficiaries Under Use of

Their Benefits is Driving Health Care Cost

 

An analysis of Medicare claims data, conducted by the National Minority Quality Forum (The Forum), covering a six-year period provides strong signals that Medicare beneficiaries with chronic diseases on whom Medicare spends the least are a major factor contributing to rising costs.  Results from this analysis show that beneficiaries with diabetes who consume the least-as evidenced by the level of reimbursement associated with their care-are more likely to cost the program significantly more in the short term.

These findings, with implications for health care reform, have prompted the formation of the Diabetes Care Project (DCP) (www.diabetescareproject.org).  Founded by The Forum and Roche Diagnostics, DCP is a new coalition of patient advocates and health partners who are committed to dramatically reducing acute events that are a consequence of diabetic complications through early interventions and improved chronic-care management.

About Diabetes

Diabetes is a growing public health epidemic affecting over 23 million Americans. According to the American Diabetes Association and the Centers for Disease Control, type 2 diabetes, fueled by rising rates of obesity, accounts for nearly 90-95 percent of all diabetics and disproportionately affects minority and aging populations in the US (nearly 20 percent of Medicare beneficiaries have diabetes). The U.S. spends approximately $174 billion in annual total costs for diagnosed diabetes with $166 billion in direct medical costs. Further, one out of every four Medicare dollars is spent on beneficiaries with diabetes, with a high percentage attributed to tertiary illness caused by unmanaged or undermanaged diabetes.

About the National Minority Quality Forum

The National Minority Quality Forum (http://www.nmqf.org) was founded in 1998 as a nonprofit organization. Its mission is to strengthen national and local efforts to eliminate the disproportionate burden of premature death and preventable illness in racial and ethnic minorities and other special populations through the use of evidence-based, data-driven initiatives, including a series of health atlases (http://www.z-atlas.com).


About American Association of Diabetes Educators

AADE is a multi-disciplinary professional membership organization dedicated to improving diabetes care through education. With more than 12,000 professional members including nurses, dietitians, pharmacists, physicians, and others, AADE has a vast network of practitioners involved in the daily treatment of diabetes patients. Collectively, our alliances, member practitioner networks, and academic partners uniquely position AADE at the locus of change for the future treatment of diabetes.

For more information, please visit: www.diabeteseducator.org.


About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients’ condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management-from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems.

For more information, please visit accu-chek.com.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.

In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R & D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche-diagnostics.us.

About Healthways


Healthways is the leading provider of specialized, comprehensive solutions to help millions of people maintain or improve their health and well-being and, as a result, reduce overall costs. Healthways’ solutions are designed to help healthy individuals stay healthy, mitigate and slow the progression to disease associated with family or lifestyle risk factors and promote the best possible health for those already affected by disease. Our proven, evidence-based programs provide highly specific and personalized interventions for each individual in a population, irrespective of age or health status, and are delivered to consumers by phone, mail, internet and face-to-face interactions, both domestically and internationally. Healthways also provides a national, fully accredited complementary and alternative Health Provider Network and a national Fitness Center Network, offering convenient access to individuals who seek health services outside of, and in conjunction with, the traditional healthcare system.

For more information, please visit: www.healthways.com

AMERICAN WARRIOR SEVERELY INJURED IN AFGHANISTAN RECEIVES HISTORIC ISLET CELL TRANSPLANT


Diabetes Research Institute aids in life-saving procedure on Thanksgiving

(December 15, 2009)  A 21-year-old airman severely injured while serving his country in a remote area of Afghanistan is recovering at Walter Reed Army Medical Center (WRAMC) in Washington, D.C. after several surgeries and an unprecedented transplant. The extraordinary care is an example of military and civilian medical experts working together in the first known case of a successful isolation and transplantation of insulin-producing cells following a severe trauma requiring complete removal of the pancreas.  Camillo Ricordi M.D. and his team at the Diabetes Research Institute played a major role in the life-saving effort.

The airman was struck by three high velocity bullets on November 21 and was operated on twice by surgeons in forward combat medical bases in Salerno and Bagram, both in Afghanistan.  The surgeries included a rare but life-saving trauma Whipple, in which the head of the pancreas, a portion of the stomach, gallbladder, and entire duodenum were removed.  In addition, a portion of the airman’s large and small bowels were also removed.

A procedure to prevent infection was later performed at a military base in Germany, before the wounded warrior was transferred by the Air Force Critical Care Air Transport teams to Walter Reed four days after the initial injury.

The airman was taken back to the operating room at Walter Reed by Dr. Craig Shriver, chief of general surgery, to have his entire intra-abdominal structure reconstructed. During this operation, what was remaining of the airman’s pancreas was found to be damaged beyond repair from the gunshot wounds. “The optimal procedure at this point was to remove his entire remaining pancreas to prevent further leakage of the pancreatic enzymes and control the bleeding, which could be fatal,” said Dr. Shriver. “We knew that the procedure would lead to the most severe and life-threatening form of diabetes, which tends to be very brittle and difficult to control in this type of situation.”

At this point in the operation, Dr. Shriver sought the opinion of Dr Rahul Jindal, a transplant surgeon at Walter Reed and a clinical professor of surgery at George Washington University in Washington, D.C.  Dr. Jindal had training and experience in islet cell transplantation, which is considered the best hope for curing diabetes.

In islet cell transplantation, the insulin-producing islets are isolated from a donor pancreas and then reinfused in a patient’s liver where they later begin to produce insulin.

“Isolation and purification of pancreatic islets is a very intricate procedure which requires a specialized laboratory, and there are only a few such facilities in the United States,” said Dr. Jindal.  “I knew the Diabetes Research Institute at the University of Miami Miller School of Medicine had such a facility and I put a call in to its director, Dr. Camillo Ricordi, for his assistance in isolating the islets from our airman’s removed pancreas.”

Dr. Ricordi, scientific director at the Diabetes Research Institute, developed the method for isolating the islet cells from the pancreas and is considered a pioneer in the field. He immediately agreed to help, in his words, “anything to help a wounded warrior.”

Dr. Shriver proceeded to remove the remaining portion of the pancreas; and Drs. Jindal and Eric Elster, a Navy transplant surgeon, flushed the harvested pancreas and intact spleen with a special preservation solution, packed it in ice and transported it by courier to Miami.

“The organ arrived at 11 o’clock the night before Thanksgiving, and my cell processing team at the Diabetes Research Institute spent the next six hours performing the islet isolation and purification procedure,” explains Dr. Ricordi.  “More than 220,000 purified islets were then suspended in a specialized cold solution and flown back to Walter Reed.”

Late in the afternoon on Thanksgiving Day, the cells were successfully injected into the patient’s portal vein into his liver with Dr. Ricordi and his team coordinating the procedure via an internet connection with surgeons at Walter Reed.

Less than one week after surgery, there was clear evidence of pancreas islet function in the wounded warrior’s liver, as shown by the presence of a specialized blood test called c-peptide. Fifteen days after the procedure, that same blood test indicated the transplanted islet cells were functioning in the normal range. As time goes on, the pancreatic islets in the liver will take up new blood supply and the patient’s requirement of exogenous insulin is expected to further decrease, facilitating diabetes management and preventing the onset of complications of the disease, and improving his overall quality of life.

Teamwork and close coordination between the many professionals in the entire Military Trauma System at Walter Reed and at the Diabetes Research Institute at the University of Miami made this possible. This procedure may allow for more cases of islet transplantation following traumatic injury to the pancreas, where purification and transplantation of the insulin producing cells from even a segment of the rescued organ could prevent the development of severe diabetes and its complications.

Teen pop sensation Nick Jonas (of The Jonas Brothers) addresses the National Press Club on the topic of juvenile diabetes.

NICK JONAS SPEAKS AT NATIONAL PRESS CLUB IN EFFORT TO EDUCATE, SUPPORT, AND INSPIRE KIDS WITH DIABETES

Teen pop sensation Nick Jonas (of The Jonas Brothers) addresses the National Press Club on the topic of juvenile diabetes.

Washington, DC (August 24, 2009) - Nick Jonas today made a passionate plea to an audience of journalists at the National Press Club asking them to raise more awareness about type 1 diabetes to motivate young people like him and their families to properly manage their condition. Nick, 16, is one of the youngest guests ever invited to speak at the Club. He talked about his own journey with diabetes, the charitable efforts of the Jonas Brothers’ Change for the Children Foundation and why he embraces the role of diabetes ambassador.

Nick recounted that until he was diagnosed with type 1 diabetes almost four years ago, he didn’t know anything about, or anybody else with, the condition. That has all since changed. With the love and support of his family, he has learned how to live with and manage his condition. He wrote the song, “A Little Bit Longer,” to share that experience and inspire others. In 2007 Nick went public with his diabetes. The impact of that announcement and his subsequent work with the Bayer Diabetes Care NicksSimpleWins.com campaign has had far reaching global impact, helping to raise awareness of the disease. Much more needs to be done, he said, and he asked reporters to help.

“So many fans with diabetes from all over the world share their stories and thank me for being an inspiration to them,” said Nick. “It’s important for them to know that they motivate and inspire me as well. I’m lucky to have a great support system in my family as well as the tools I need to manage my diabetes properly. By speaking publicly about my experience I hope to increase diabetes awareness, encourage diabetes education and help fundraising for research and other programs for kids with diabetes. The more you report about diabetes, the more people will know,” he told members of the press.

Nick’s passion for helping other young people with diabetes by sharing his experience is just one of the ways he “gives back” to fans. He and his brothers, Kevin and Joe, started the Jonas Brothers’ Change for the Children Foundation through which they donate funds to several causes including pediatric diabetes research, education and treatment.

 ”When Nick talks about diabetes, people listen. And until there is a cure, the greatest weapon against diabetes is increased awareness and knowing how to manage it,” said Nancy Katz, head of North America for Bayer Diabetes Care. “That includes working with a health care professional for guidance on regular monitoring of blood sugar and A1C levels, proper diet and exercise and having a positive attitude to achieve every day simple wins.”

Since the announcement of their partnership last year, Bayer and Nick have taken many steps to inspire young people with diabetes to achieve their simple wins: small, everyday victories for managing diabetes that can lead to big differences over time.

In recognition of his efforts in raising diabetes awareness over the past year, Bayer presented Nick with another $100,000 donation to the Jonas Brothers’ Change for the Children Foundation to support its ongoing commitment to pediatric diabetes.

In August 2008, announcing the start of their partnership with Nick, Bayer presented the Jonas Brothers with a $100,000 donation for their foundation. In the interim, Nick and Bayer created special dog tags, like the one Nick wears featuring a lyric from his song, “A Little Bit Longer.” Proceeds from the sales of the dog tags benefit the Jonas Brothers’ Change for the Children Foundation. The dog tags are available through www.NicksSimpleWins.com for a donation of $5. Since the dog tag program launched in November 2008, it has raised an additional $75,000 for the Jonas Brothers’ Change for the Children Foundation.

As this year marks the 40-year anniversary since Bayer introduced the first portable blood glucose meter, the company hopes that its ongoing partnership with Nick reinforces their commitment to diabetes management. To learn more about Nick’s personal experiences with diabetes, his programs with Bayer and to read his blog, please go to www.NicksSimpleWins.com.

Bayer Diabetes Care

Bayer Diabetes Care is a worldwide leader in diabetes, supports customers in 100 countries and for more than 40 years, has led the way in diabetes care product innovation. Bayer introduced the first portable blood glucose meter and test strips, innovated the measurement of A1C (glycated hemoglobin) and was the first to offer a suite of blood glucose monitors (CONTOUR® and BREEZE®2) with No CodingTM technology and no interference with common substances such as maltose. Today, Bayer Diabetes Care offers an unparalleled choice in diabetes management systems and comprehensive support including education, tools and resources designed to simplify life with diabetes.

Bayer Diabetes Care is a business of the Bayer HealthCare LLC, Medical Care Division and has its global headquarters located in Tarrytown, New York. For more information visit www.bayerdiabetes.com.

 

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Bayer Schering Pharma, Consumer Care and Medical Care divisions. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Great news for Deltec Cozmo users!


Changing your insulin pump company is a hard decision even under the best of circumstances. If you are a Deltec Cozmo user, you now find yourself in a very difficult position with the recent announcement that Smiths Medical will no longer be producing insulin pumps. Here at Roche Diagnostics, the makers of ACCU-CHEK® brand diabetes care products, we understand the challenge you now face and we want to do everything we can to make your transition as simple as possible.

To that end, we’ve designed the ACCU-CHEK Alliance Program just for Deltec Cozmo users offering an easy and affordable transition to a brand new ACCU-CHEK Spirit insulin pump system. If your Cozmo insulin pump is still in-warranty, here’s what you’ll receive when you sign up for the program:

  • The ACCU-CHEK® Spirit insulin pump system* without charge with the trade-in of your Cozmo Pump.
  • 2 Year Warranty
  • 30 Day Supply Starter Kit
  • Upgrade certificate for a new insulin pump system launched in the future by Roche Diagnostics without additional charge with your trade-in of the ACCU-CHEK Spirit insulin pump. Certificate expires 2 years from shipment date of ACCU-CHEK Spirit insulin pump.

*The system includes the ACCU-CHEK Spirit insulin pump, ACCU-CHEK blood glucose meter of your choice, Palm® PDA and the ACCU-CHEK Pocket Compass Software with bolus calculator.

So not only are you receiving a new insulin pump system (brand new, not refurbished!), but you’re alsogetting the peace of mind in knowing that you’ve got a future upgrade at no additional charge when new technology becomes available.

If you’d like to learn more about this special offer or about the ACCU-CHEK Spirit insulin pump system, please call us at 866-703-3476. This is a limited time offer and only available to current in-warranty Deltec Cozmo users, so contact us today!

Terms and Exclusions:

  • This promotion is effective from August 1, 2009, but may be discontinued or modified at any time without notice.
  • Only in-warranty Deltec Cozmo insulin pump users are eligible.
  • Available to U.S. residents only. Persons covered by federal, state or government-funded healthcare programs (such as Medicare, Medicaid, Veterans Administration) and the residents of Massachusetts may not participate.

No Sugar Added™


Welcome to Diabetes Living Today® ~ No Sugar AddedTM Blog.  Here you can read writing by Kitty Castellini of what it was like for her to live with type 1 diabetes for over 40 years  and her battle to find a cure through a successful “Pancreas Transplant Alone.”  Kitty will also share with her readers what life is like today to be “insulin~free.”  Follow Kitty as she travels to interview “World Class” Research Scientist to learn about cure-focus research.

No Sugar AddedTM Blog will also feature, “Exclusive Guest Post” by many known Authors.  Here you will find that things are not “sugar coated!” We invite to join our blogs with your comments and to also submit your writing for publication.

Call Me Patient, Not Consumer

Diabetes Living Today is happy to have our friend Manny Hernandes, co-founder of TuDiabetes.  Manny has written an “exclusive guest post for our reader’s: 

Call Me Patient, Not Consumer

(or why trust is key for Health 2.0 to continue to make progress)Last year, I had the honor to present TuDiabetes at Health2.0 2008 in San Francisco (http://tudiabetes.com/video/tudiabetes-at-health-20-2008). The conference dealt with empowering patients through support, tools and information to help them better manage their health.You would imagine that technologies and platforms for patient empowerment would have patients at the center. And they do to a great degree, except for the fact that patients were routinely referred to as consumers, not as patients, throughout the conference. Most of the people I pointed this out to didn’t notice it. Some didn’t think it was an issue.So, is it a big deal that patients are called consumers? It is if you THINK of them as consumers first and patients second. That puts a bigger emphasis on how much profit the patient can make a company, which can lead to less-than-optimal decisions on behalf of the patient later on.There is nothing wrong with profits resulting from offering products or services to patients to help them improve their health. But this is a case where the order of the factors affects the final result. If this sounds to you like an extreme view, consider your own experience when dealing with insurance companies (http://tudiabetes.com/forum/topics/health-insurance-social).What does this patient and consumer talk have to do with diabetes? As one of the most common chronic diseases, I want to see diabetes turn into an example of the direction Health 2.0 will take, with patient health improvement as the most important goal.

Support

Healthier lives result from connections with other patients: people you not only can relate to but people that you trust. Clay Shirky, author of the book, “Here Comes Everybody” puts it in very clear terms: “… whenever people decide to trust one another, information will flow.”This is why one of the fastest growing areas in Health 2.0 has to do with patient communities. Networks like TuDiabetes and DiabetesDaily (structured spaces where patients get support from others they trust) and slightly more organic networks, like Twitter , where patients share what they do with their diabetes management in 140 characters or less are very good examples of this trend. You can join the growing number of Twitter users with diabetes at: http://tudiabetes.com/group/twitterbeticsIn 2009, networks and platforms that keep on improving the channels for patients to support each other will continue to grow and positively impact the lives and health of many more.

Tools

In the course of 2008 there was a lot of talk in Health 2.0 circles about electronic Personal Health Records. Microsoft took a stab at them with HealthVault. Google tried to tackle them through Google Health . A lot remains to be done, but with the emphasis placed by the new administration on health care and PHRs specifically, I would not be surprised if we see important progress in this front in 2009.If the element of trust is important in the case of support networks, it becomes critical in the case of tools like these. Before people feel comfortable letting their health information reside online, important progress needs to be made to make everyone comfortable with this idea. This is an area where treating the patient as a patient and not a consumer is fundamental as well.

Information

Google, WebMD, HealthLine, RightHealth, OrganizedWisdom, HealthLibrarian. There are tons of resources: from the generic search engines to the specific sites that focus on health. This makes life for patients searching for information about their symptoms or disease harder than necessary.Sure it’s easy to find information, but is it the answer to your specific question? Is it reliable? Is it raw information or has it been edited? Who gets to edit it and why? So many questions come up that patients commonly resort to support communities to post their questions when they feel overwhelmed or they simply cannot trust the information they have found.These kinds of online queries cannot substitute asking a medical professional. But between appointments, resources that can be trusted to answer important questions need to be available. In 2009, I foresee support networks stepping up to the plate to start filling this need through content vetted by medical professionals. Along with this, the concept of virtual visits (also called e-visits to the doctor) will continue to pick up steam throughout the year and into 2010.

Patients First

There is no doubt: the health space has changed and it is not going back. If anything it’s going to keep changing. I hope the changes will be for the better, but considering how much more empowered patients are becoming, I feel this will be the case.Now, through our blogs, communities and the diabetes OC at large, we need to work hard to make the promise of Health 2.0 available to everyone. Until then, to all providers: please don’t call me consumer. Call me patient.

January 6, 2009 ~ Dr. David A. Laskin, Internal Medicine

This week Kitty and Dr. Fallon will interview Dr.David A. Laskin , Internal Medicine. Listener’s are invited to call in with their questions and comments. Tuesday Evening 8:00PM ~ 9:00PM (EST) Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com Call In: 856-696-0092

Dr. David A. Laskin


Dr. Laskin is a practicing primary care clinician in Gloucester County, NJ, being board certified in Internal Medicine and Geriatrics.  He is the lead physician in a four doctor Internal Medicine practice and is an attending physician at Underwood Memorial Hospital in Woodbury, New Jersey since 1982.  He also serves as the medical director of the Transitional Care Unit, a 17 bed unit specializing in rehabilitation.  He is one of only 2500 Certified Medical Directors in the country.

His interests in the field of medicine revolve around preventive health care, stressing proper nutrition, exercise, and being proactive about health.  By practicing medicine “the old fashioned way,” where a doctor can really make a difference in someone’s life,
Dr. Laskin has been able to be quite active in his community and spend the necessary time with his patients in the office, as well as deliver educational seminars to help people stay healthy!

Outside of practicing medicine, Dr. Laskin is an avid cyclist, participating in the American Cancer Society and MS 150 bike rides annually.  He has been happily married to his wife, Carol, and they have two college-aged daughters that bring them much joy!  He wishes everyone a very happy and healthy New Year!

Photo Above:  Dr. David A. Laskin




 

 

 

Diabetes News Today

 

Diabetes

 

 

 

Gastric Bypass Halts Diabetes in Obese Teens

Washington Post

- Dec 29, 2008

- 22 hours ago

29 (HealthDay News) — Obese teenagers who have gastric bypass surgery not only lose weight but see their type 2 diabetes disappear, a new study finds.

Related Articles »

clipped from Google - 12/2008

 

 

Liberty Healthcare to buy diabetes-supply business

Forbes

, USA

- Dec 29, 2008

- 13 hours ago

By MARLEY SEAMAN , 12.29.08, 06:19 PM EST Medical-supply distributor Owens & Minor Inc. said Monday it will sell its direct-to-consumer diabetes-supply

Related Articles »

clipped from Google - 12/2008

 

 

Quarterback keeps his diabetes in check

Asbury Park Press

, USA

- Dec 30, 2008

- 3 hours ago

You’d never guess the quarterback spends a good portion of every game on the sidelines keeping tabs on his type 1 diabetes, a condition that,

Related Articles »

clipped from Google - 12/2008

 

 

Biking, spinning and diet control diabetes

Indianapolis Star

- Dec 30, 2008

- 6 hours ago

That was an eye-opener for me — diabetes and the heart attack. Being diabetic scared me more than anything. I told the people with ProMotion Fitness I

clipped from Google - 12/2008

 

powered by

 


 

Feed Buttons

  • Any Podcatcher
  • Any Feed Reader


 

Why I Blog by Kerri Morrone Sparling

Diabetes Living Today is happy to have our friend Kerri Morrone Sparling as our guest tonight, Tuesday December 30, 2008.  She has written an “exclusive guest post“, Why I Blog for our reader’s.


Why I Blog

Kerri Morrone Sparling

The human body is absolutely amazing in the way each organ works together with such precision, maintaining our homeostasis and keeping us kicking.

But the mind of a diabetic is pretty amazing, too. We have trained our minds to think like a pancreas. We are the people who know how many carbs are floating around in a bowl of cereal. We are the ones who can take a blood sugar number and fold it into any situation - 140 mg/dl on the soccer field means more orange slices while 140 mg/dl at the dinner table means correcting the high and navigating the meal. We are the ones who are trying to compensate for some cells that simply gave out on us. Crawling inside the thoughts of a working pancreas and trying to mimic its performance is not an easy task.

When I was diagnosed with type 1 diabetes in 1986, my parents and I were instructed how to inject insulin into oranges, handed a generic meal plan, and given a “Bill Nye the Science Guy” test tube set to check my urine glucose. Over the course of the last two decades, I have seen remarkable advancements in diabetes technology, from fast-acting insulins like Humalog and 5 second glucose meters to insulin pump therapy and continuous glucose monitoring systems.

But despite this influx of information and technology, I was still one of the only diabetics I knew, completely loved but not completely understood by my friends and family. I didn’t feel sick. I felt frustrated. And alone. I have had diabetes for most of my life, so by necessity I knew the technical essentials. But where were all the people who were living with this disease, like I have been since I was small?

When I first researched diabetes on Google, the page filled with a litany of links and lists of ways I could become “complicated,” urging me to take fastidious care of my feet, to schedule annual eye exams, and discussing the benefits of testing my blood sugar at least four times per day. It wasn’t that this information was useless to me, but it was mostly clinical statistics and besides, who were these people writing this stuff?

At the recommendation of my now-husband, I started a blog called Six Until Me, referring to my age when the first signs of diabetes presented themselves. Six years until diabetes - six until me. How it touches every day life, from the spotty scars on my fingertips to the dots of past infusion sets on my thighs that tell a silent story.

Blogging has changed my perception of diabetes from one of loneliness to being embraced by a network of support. It’s about sharing these feelings and forcing me to deal with these emotions, keeping diabetes from being an isolating force in my life. In addition, what started as a means of connecting with other diabetics ultimately grew into a terrific career as an editor and columnist at dLife, where I see daily the profound and empowering effects of a strong and empowered community.

Every day we, as people with diabetes or their caregivers, face this disease. And every day is easier knowing there are people out there who understand completely.

This is why I blog.

 

Photo Above:  Kerri Morrone Sparling

Kerri Sparling writes the widely-read and award-winning diabetes blog Six Until Me, about her life as a twenty something with type 1 diabetes. In addition to her blog, she is also an Editor and columnist for dLife, and a columnist for several diabetes publications. Recently married, Kerri currently lives in Connecticut with her husband and their army of cats.

12/23/06 ~ Thomas Dayspring, M.D., FACP North Jersey Institute of Menopausal Lipidology

This week Kitty and Dr. Fallon will interview Dr. Thomas Dayspring, North Jersey Institute of Menopausal Lipidology, Newark, N.J. Listener’s are invited to call in with their questions and comments. Tuesday Evening 8:00PM ~ 9:00PM (EST) Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com Call In: 856-696-0092

Thomas Dayspring, MD, FACP

Director: North Jersey Institute of Menopausal Lipidology

Dr. Thomas Dayspring is a diplomate of both the American Board of Internal Medicine and American Board of Clinical Lipidology. He is also a certified menopause practitioner by the North American Menopause Society. He is a Clinical Assistant Professor of Medicine at the University of Medicine and Dentistry of New Jersey - New Jersey Medical School and is an attending in Medicine at St. Joseph’s Regional Medical Center in Paterson and Wayne, NJ.  His private medical practice of 33 years is currently limited to consulting patients with complex lipid disorders.

He is a Fellow of the American College of Physicians, a member of the American Heart Association Council on Atherosclerosis and several other organizations. He is a board member of the Northeast Chapter of the National Lipid Association and is listed in the Guide to America’s Top Physicians. He is a faculty member of the Master’s of Lipidology Course offered by the National Lipid Association and on the Editorial Board of the Journal of Clinical Lipidology.

He is one of the most requested speakers in the United States with expertise on atherothrombosis, lipoprotein and vascular biology, advanced lipoprotein testing, and the CV effects of estrogen and selective estrogen receptor modulation. Dr. Dayspring has given over 2500 lectures, including over 700 hospital and medical school grand rounds, large CME programs in all 50 states and multiple other speaking venues such as teleconferences and web casts during the last eleven years.

He is the author of a chapter on cholesterol synthesis, absorption and excretion in the 2008 textbook, Therapeutic Lipidology as well as several articles relating to lipids and lipoproteins including their pharmacologic modulation and their relationship to gender, estrogen and raloxifene. He also authors “Lipidaholics Anonymous” a biweekly newsletter received by several thousand healthcare professionals. He is a Power Point expert and has created multiple animated slides, including CME CDs, relating to all aspects of lipidology and atherosclerosis.

Photo Above:  Dr. Thomas Dayspring



12/16/08 ~ Dr. Charles R. Egoville, Pulmonary & Critical Care Medicine

This week Kitty and Dr. Fallon will interview Dr. Charles R. Egoville, Pulmonary & Critical Care Medicine. Listener’s are invited to call in with their questions and comments. Tuesday Evening 8:00PM ~ 9:00PM (EST) Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com Call In: 856-696-0092

Charles R. Egoville, M.D., F.C.C.P.

Pulmonary and Critical Care Medicial


Following my graduation from the New Jersey College of Medicine and Denistry, I trained at Philadelphia General Hospital and the Hospital of the University of Pennsylvania.  I subsequently practiced Pulmonary and Critical Care Medicine in the Philadelphia and South Jersey areas for 35 years.

My particular interests include the treatment of asthma, performing diagnostic and therapeutic fiberoptic bronchoscopy, and the care and management of critically ill patients in the intensive care unit.  I also enjoyed the opportunity to teach medical studies and internal medicine residents.

For more information on Dr. Charles R. Egoville click here.
Dr. Egoville is currently Chief of Pulmonary Medicine at the Underwood-Memorial Hospital in Woodbury, New Jersey.    

Photo Above:  Dr. Charles R. Egoville